NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial

SIMPLE SUMMARY: A hepatocellular carcinoma (HCC) is the most common cause of death in patients suffering from chronic liver diseases. In order to improve the prediction of outcomes in HCC patients, there is a need for new biomarkers. This pilot study aimed at identifying serum metabolites for the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyer, Thomas, Rübenthaler, Johannes, Alunni-Fabbroni, Marianna, Schinner, Regina, Weber, Sabine, Mayerle, Julia, Schiffer, Eric, Höckner, Sebastian, Malfertheiner, Peter, Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199928/
https://www.ncbi.nlm.nih.gov/pubmed/34205110
http://dx.doi.org/10.3390/cancers13112787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199928/
https://www.ncbi.nlm.nih.gov/pubmed/34205110
http://dx.doi.org/10.3390/cancers13112787

Ejemplares similares